Back

Systematic GWAS-assessment of disease modules reveals a multi-omic MS module strongly associated with risk factors

Badam, T. V. S.; de Weerd, H. A.; Martinez-Enguita, D.; Olsson, T.; Alfredsson, L.; Kockum, I.; Jagodic, M.; Lubovac-Pilav, Z.; Gustafsson, M.

2020-10-26 bioinformatics
10.1101/2020.10.26.351783 bioRxiv
Show abstract

BackgroundThere are few (if any) practical guidelines for predictive and falsifiable multi-omics data integration that systematically integrate existing knowledge. Disease modules are popular concepts for interpreting genome-wide studies in medicine but have so far not been systematically evaluated and may lead to corroborating multi-omic modules. MethodsWe assessed eight module identification methods in 57 previously published expression and methylation studies of 19 diseases using GWAS enrichment analysis. Next, we applied the same strategy for multi-omics integration of 19 datasets of multiple sclerosis (MS), and further validated the resulting module using both GWAS and risk-factor associated genes from several independent cohorts. ResultsOur benchmark of modules showed that in immune-associated diseases modules inferred from clique-based methods were the most enriched for GWAS-genes. The multi-omics case study using MS revealed the robust identification of a module of 220 genes. Strikingly, most genes of the module was differentially methylated upon the action of one or several environmental risk factors in MS (n = 217, P = 10-47) and were also independently validated for association with five different risk factors of MS, which further stressed the high genetic and epigenetic relevance of the module for MS. ConclusionWe believe our analysis provides a workflow for selecting modules and our benchmark study may help further improvement of disease module methods. Moreover, we also stress that our methodology is generally applicable for combining and assessing the performance of multi-omics approaches for complex diseases.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
BMC Medical Genomics
36 papers in training set
Top 0.1%
18.6%
2
Frontiers in Genetics
197 papers in training set
Top 1%
4.9%
3
Journal of Translational Medicine
46 papers in training set
Top 0.1%
4.9%
4
Scientific Reports
3102 papers in training set
Top 26%
4.4%
5
PeerJ
261 papers in training set
Top 1%
4.4%
6
Frontiers in Immunology
586 papers in training set
Top 2%
4.0%
7
PLOS ONE
4510 papers in training set
Top 37%
3.7%
8
Briefings in Bioinformatics
326 papers in training set
Top 2%
3.7%
9
Computational and Structural Biotechnology Journal
216 papers in training set
Top 1%
3.7%
50% of probability mass above
10
Bioinformatics
1061 papers in training set
Top 6%
2.4%
11
International Journal of Molecular Sciences
453 papers in training set
Top 6%
1.9%
12
Neurobiology of Disease
134 papers in training set
Top 2%
1.7%
13
Nucleic Acids Research
1128 papers in training set
Top 10%
1.7%
14
Immunology
29 papers in training set
Top 0.4%
1.7%
15
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 32%
1.7%
16
BMC Bioinformatics
383 papers in training set
Top 5%
1.5%
17
Frontiers in Medicine
113 papers in training set
Top 4%
1.5%
18
Clinical Epigenetics
53 papers in training set
Top 0.7%
1.2%
19
Nature Communications
4913 papers in training set
Top 58%
1.0%
20
Computers in Biology and Medicine
120 papers in training set
Top 4%
0.9%
21
Frontiers in Neurology
91 papers in training set
Top 4%
0.9%
22
Epigenetics
43 papers in training set
Top 0.8%
0.8%
23
Journal of Advanced Research
15 papers in training set
Top 0.7%
0.8%
24
Frontiers in Pharmacology
100 papers in training set
Top 4%
0.8%
25
Annals of Clinical and Translational Neurology
29 papers in training set
Top 1%
0.7%
26
Brain, Behavior, and Immunity
105 papers in training set
Top 3%
0.7%
27
Brain Communications
147 papers in training set
Top 4%
0.7%
28
Medicine
30 papers in training set
Top 3%
0.7%
29
Brain Sciences
52 papers in training set
Top 2%
0.7%
30
Bioinformatics Advances
184 papers in training set
Top 5%
0.7%